Cross-cultural and comparative epidemiology of insomnia: the Diagnostic and Statistical Manual (DSM), International Classification of Diseases (ICD) and International Classification of Sleep Disorders (ICSD)

Chung, Ka Fai; Yeung, Wing‐Fai; Ho, Fiona Yan Yee; Yung, Kam Ping; Yu, Branda Yee Man; Kwok, Chi Wa

doi:10.1016/j.sleep.2014.10.018

Cited by 183 publications

(102 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[2][3][4][5][6] When using the ICSD-3 diagnostic criteria the prevalence of chronic insomnia is 9% 7 8 to 12%, 3 9 with transient symptoms of insomnia reported in 22-35% of the population. [3][4][5][6][7][8][9][10] The incidence of chronic insomnia in community dwelling adults in the United States, United Kingdom, and Taiwan has been reported to be 2.3-7.3% per year. [11][12][13] It is also a costly disease, in both healthcare utilization and absenteeism, 14 15 and it is associated with an increased risk of mortality (adjusted hazard ratio 1.58-2.74) 16 17 and statistically significant risk of morbidity.…”

Section: Incidence and Prevalencementioning

confidence: 99%

Advances in the management of chronic insomnia

Kay-Stacey

Attarian

2016

BMJ

122

View full text Add to dashboard Cite

Chronic insomnia is a common condition that affects people worldwide and has negative effects on patients' health and wellbeing. The treatment of insomnia can be complex and time consuming for patients and providers. Although behavioral interventions are the first line therapy, there are barriers to access for these treatments. However, in recent years, alternative ways of providing these behavioral therapies that make them more widely available have been investigated. Drugs also play an important role in the treatment of insomnia and new drugs have been introduced as options for treating patients with sleep initiation and sleep maintenance insomnia. In this review, we will discuss advances in the past six years in both non-pharmacologic and pharmacologic treatments for patients with chronic insomnia. We will also review the controversies surrounding some of the current drug treatments, as well as the role that technology and personal activity monitoring devices may play in treating insomnia.

show abstract

Section: Incidence and Prevalencementioning

confidence: 99%

Advances in the management of chronic insomnia

Kay-Stacey

Attarian

2016

BMJ

122

View full text Add to dashboard Cite

show abstract

“…Fatigue is the most frequently reported daytime symptom in patients with insomnia (Chung et al, 2015b;Espie et al, 2012), but the relationship between fatigue and insomnia is not straightforward. Sánchez-Ortuño et al, (2011) found that the type and severity of daytime symptoms varied with insomnia subtypes.…”

Section: Discussionmentioning

confidence: 99%

Correlates of residual fatigue in patients with major depressive disorder: The role of psychotropic medication

Chung

Yeung

2015

Journal of Affective Disorders

Self Cite

View full text Add to dashboard Cite

“…The randomization procedure and telephone interview, conducted by the Public Opinion Programme, University of Hong Kong, have been presented in our original paper [15]. At the time of the study, the fixed telephone line density in Hong Kong was 102 lines per 100 households, which was among the highest in the world.…”

Section: Participantsmentioning

confidence: 99%

Predictors of Daytime Consequences of Insomnia: The Roles of Quantitative Criteria and Nonrestorative Sleep

Chung¹,

Yeung²,

Ho³

et al. 2018

Psychopathology

Self Cite

View full text Add to dashboard Cite

Background: The implications of removing nonrestorative sleep (NRS) and adding quantitative criteria in the most recent diagnostic criteria of insomnia disorder remain unresolved. The study was aimed to investigate how nighttime quantitative measures of sleep quality and NRS relate to daytime functioning in a general population sample. Sampling and Methods: Data of 905 subjects (mean age = 47.0 years; 64.5% females) in a population-based survey who had insomnia symptoms or NRS at least 1 night in a typical week were analyzed to evaluate their relationship with “functional impairment,” “concerns/distress,” and “interference with daily activities” over the past 30 days. Receiver-operating characteristic curve analysis was performed, while controlling for age and gender. Results: Moderate to severe NRS was the first-level predictor of all 3 daytime variables. Insomnia frequency ≥3 times per week and sleep onset latency ≥10–20 min were second-level predictors. Conclusions: We found that NRS was more important than insomnia symptoms in determining daytime consequences of insomnia. On the basis of our findings we express concerns whether the removal of NRS from the most recent diagnostic criteria may lead to its underrecognition, but support the quantitative criteria on insomnia frequency of at least 3 nights per week.

show abstract

Cross-cultural and comparative epidemiology of insomnia: the Diagnostic and Statistical Manual (DSM), International Classification of Diseases (ICD) and International Classification of Sleep Disorders (ICSD)

Cited by 183 publications

References 32 publications

Advances in the management of chronic insomnia

Advances in the management of chronic insomnia

Correlates of residual fatigue in patients with major depressive disorder: The role of psychotropic medication

Predictors of Daytime Consequences of Insomnia: The Roles of Quantitative Criteria and Nonrestorative Sleep

Contact Info

Product

Resources

About